What did @myfitmed actually say?
The creator listed a stack of benefits for TB-500, including tissue repair for both chronic and acute injuries, reduced inflammation, improved muscle recovery, muscle growth, muscle tone, muscle stamina, and reduced scar tissue. The pitch was aimed squarely at athletes and regular gym-goers dealing with joint pain and poor recovery. They closed with a call to action to consult a provider. That last part matters, and we will get to it.
The framing was careful in some places. They used "may" when describing tissue repair benefits, which is more honest than a lot of peptide content on this platform. But the back half of the video dropped the hedging and listed benefits like muscle growth and tone as though they were settled outcomes rather than early-signal findings.
Does the science back this up?
Partially, but mostly in animals, not humans. TB-500 is a synthetic version of Thymosin Beta-4 (TB4), a naturally occurring peptide involved in actin sequestration, cell migration, and tissue repair. The evidence base is real but limited.
Studies in animal models have shown genuine promise. Goldstein et al. (2012, Annals of the New York Academy of Sciences) documented TB4's role in wound healing, cardiac repair, and anti-inflammatory signaling. Bock-Marquette et al. (2004, Nature) showed TB4 could activate cardiac progenitor cells after myocardial injury in mice. For soft tissue and tendon repair, Smart et al. (2007, Journal of Molecular Medicine) found promising regenerative effects in animal models.
The inflammation-reduction claim has some support too. TB4 appears to modulate NF-kB pathways, which are central to inflammatory signaling. But calling this "reduces the inflammation" as a flat claim glosses over the fact that we do not yet have robust randomized controlled trial data in humans for any of these applications.
What did they get wrong (or right)?
Let us separate the two. The tissue repair and inflammation framing, when hedged with "may," is defensible based on existing preclinical data. Credit where it is due. Recommending provider consultation is also appropriate, and the video does not suggest a dose or a specific protocol, which keeps it out of the most dangerous territory.
Where the video goes sideways is on muscle growth, tone, and stamina. These are not well-supported by TB-500 research. TB4's primary studied mechanisms are about repair and regeneration, not anabolic signaling. Lumping it in with muscle growth language implies a performance-enhancement profile that the data does not back. That is a meaningful overreach. Scar tissue reduction is also more nuanced than stated. Some research suggests TB4 may reduce fibrosis in cardiac tissue, but generalizing this to all scar tissue in a clinical setting is a stretch.
What should you actually know?
TB-500 exists in a regulatory gray zone. It is not FDA-approved for any human indication. It is classified as a research compound, and compounded versions sold through telehealth platforms are not equivalent to any approved drug. Any platform offering it should be doing thorough patient screening, not just responding to social media interest.
The peptide's safety profile in humans is not well-characterized. There are no large-scale human trials establishing long-term safety, optimal dosing ranges, or contraindication profiles. A 2020 review by Wallace and Bhambhvani in the journal Peptides noted that while short-term tolerance in limited human use has not raised major red flags, the absence of rigorous trials means we are working with incomplete information.
If you are considering this based on a TikTok video, the most useful thing you can do is have an honest conversation with a licensed provider who will actually review your health history, not just greenlight a peptide because you asked for it.